103
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Benefit Effect of Sublingual Dust Mite Drops on the Control of Asthma in Children

, , , &
Pages 3431-3438 | Published online: 14 Jul 2021

References

  • National Pediatric Asthma Collaborating Group, Institute of Environmental and Health-Related Product Safety. The third epidemiological survey of childhood asthma in urban China. J Pediatr. 2013;51(10):729–735.
  • Huang K, Yang T, Xu J, et al. Prevalence, risk factors, and management of asthma in China: a national cross‐sectional study. Lancet. 2019;394(10196):407‐418. doi:10.1016/S0140-6736(19)31147-X
  • Alvaro-Lozano M, Akdis CA, Akdis M, et al. EAACI allergen immunotherapy user’s guide. Pediatr Allergy Immunol. 2020;31(Suppl25):1–101. doi:10.1111/pai.13189
  • Chen WB, Shen XF, Li Q, Zhou WC, Cheng L. Efficacy of a 3-year course of sublingual immunotherapy for mite-induced allergic rhinitis with a 3-year follow-up. Immunotherapy. 2020;12(12):891–901. doi:10.2217/imt-2020-0006
  • Giannetti A, Ricci G, Procaccianti M, et al. Safety, efficacy, and preventive role of subcutaneous and sublingual allergen immunotherapy for the treatment of pediatric asthma. J Asthma Allergy. 2020;13:575–587. doi:10.2147/JAA.S234280
  • Besh L, Slyuzar Z, Matsyura O. [Optimization of allergen-specific immunotherapy in children with bronchial asthma: selection features, patient monitoring and efficacy]. Georgian Med News. 2020;(306):67–72. [ swedish]
  • Respiratory Group of Pediatrics Branch of Chinese Medical Association, Children Respiratory Committee of Pediatrics Branch of Chinese Medical Doctor Association. Recommendations for standardized diagnosis and treatment of childhood bronchial asthma (2020). Chin J Pediatr. 2020;9:708–717.
  • Pulmonary function group, respiratory branch, Chinese medical association. Guidelines for pulmonary function examination (part II) - spirometry examination. Zhonghua Jie He He Hu Xi Za Zhi. 2014;37:481–486.
  • Pulmonary Function Cooperative Group, Respiratory Group, Pediatrics Society, Chinese Medical Association. Guidelines for indicators of lung function and airway nontraumatic inflammation in children (7): monitoring exhaled nitric oxide. Chin J Pract Pediatr. 2017;32(21):1622–1627.
  • Liu AH, Zeiger R, Sorkness C, et al. Development and cross-sectional validation of the childhood asthma control Test. J Allergy Clin Immunol. 2007;119(4):817–825. doi:10.1016/j.jaci.2006.12.662
  • Bousquet PJ, Combescure C, Neukirch F, et al. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy. 2007;62(4):367–372. doi:10.1111/j.1398-9995.2006.01276.x
  • Xiang L, Zhao J, Bao Y, et al. Expert consensus on acariespecific immunotherapy for airway allergic diseases in children. Chin J Appl Pediatr. 2015;33:1215–1223.
  • Xiang L, Zhao J, Zheng Y, et al. Uncontrolled asthma and its risk factors in Chinese children: a cross‐sectional observational study. J Asthma. 2016;53(7):699‐706. doi:10.3109/02770903.2016.1144199
  • Global Initiative for Asthma. Global strategy for asthma management and prevention; 2020. Available from: www.ginasthma.org. Accessed June 23, 2021.
  • Li HM, Jiang ZF, Zhao SY. Research progress of refractory asthma in children. Int J Pediatr. 2005;(02):113–115.
  • Klok T, Kaptein AA, Brand PLP. Non-adherence in children with asthma reviewed: the need for improvement of asthma care and medical education. Pediatr Allergy Immunol. 2015;26(3):197–205. doi:10.1111/pai.12362 PMID: 25704083.
  • Gao Y, Pan JP, Wang JM. Investigation and analysis of influencing factors for compliance of inhaled glucocorticoid therapy in children with asthma. Shaanxi Med J. 2014;43(07):916–917.
  • Wei YC, Jia LL, Hu LH, et al. Investigation on compliance of inhaled glucocorticoids in children with asthma in remission period. Chin J Hosp Pharm. 2019;14:1494–1498.
  • Pelaia C, Vatrella A, Lombardo N, et al. Biological mechanisms underlying the clinical effects of allergen-specific immunotherapy in asthmatic children. Expert Opin Biol Ther. 2018;18(2):197–204. doi:10.1080/14712598.2018.1402003
  • Canonica GW, Cox L, Pawankar R, et al. Sublingual immunotherapy: world Allergy Organization position paper 2013 update. World Allergy Organ J. 2014;7:6.
  • Wang L, Ai T, Luo R, et al. Effects of sublingual duster mite drops on lung function and exhaled nitric oxide in children with multiple and single allergic respiratory diseases. Can Respir J. 2020;2020:7430936. doi:10.1155/2020/7430936
  • Ai T, Wang L, Luo R, et al. Effects of sublingual-specific immunotherapy on pulmonary function and exhaled nitric oxide levels in asthmatic children with and without allergic rhinitis. Transl Pediatr. 2020;9(5):686–694. doi:10.21037/tp-20-322
  • Wang L, Yin J, Fadel R, Montagut A, de Beaumont O, Devillier P. House dust mite sublingual immunotherapy is safe and appears to be effective in moderate, persistent asthma. Allergy. 2014;69(9):1181–1188. doi:10.1111/all.12188
  • Ozdemir C, Yazi D, Gocmen I, et al. Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma. Pediatr Allergy Immunol. 2007;18(6):508–515. doi:10.1111/j.1399-3038.2007.00549.x
  • Dhami S, Kakourou A, Asamoah F, et al. Allergen immunotherapy for allergic asthma: a systematic review and meta-analysis. Allergy. 2017;72(12):1825–1848. doi:10.1111/all.13208
  • Asamoah F, Kakourou A, Dhami S, et al. Allergen immunotherapy for allergic asthma: a systematic overview of systematic reviews. Clin Transl Allergy. 2017;7(1):25. doi:10.1186/s13601-017-0160-0
  • Liu W, Jiang H, Pu H, et al. [An assessment of the sublingual immunotherapy with Dermatophagoides farinae on asthma control level and pulmonary function of allergic asthma and rhinitis in adult patient]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019;33(9):850–854. doi:10.13201/j.issn.1001-1781.2019.09.013 Chinese.
  • Nadir Bahceciler N, Galip N, Babayigit A. Steroid sparing effect of sublingual immunotherapy: real life study in mono/polisensitized children with asthma. Immunotherapy. 2017;9(15):1263–1269. doi:10.2217/imt-2017-0110
  • Mosbech H, Deckelmann R, de Blay F, et al. Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol. 2014;134(3):568–575.e7. doi:10.1016/j.jaci.2014.03.019